This inventor holds 1 USPTO granted patent. Top assignee: New York University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Nicole Sunseri
Introduction
Nicole Sunseri is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of immunology, particularly in the development of lentiviral vectors for HIV-1 vaccines. Her work focuses on enhancing the infectivity of viruses with respect to immune cells, which is crucial for effective vaccine development.
Latest Patents
Nicole Sunseri holds a patent for a chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism. This patent describes compositions and methods that relate to lentiviral vectors capable of generating virions that exhibit enhanced infectivity with respect to monocyte-derived macrophages and dendritic cells. The innovations outlined in her patent are aimed at producing components for vaccines that effectively stimulate innate immune responses to HIV-1.
Career Highlights
Nicole Sunseri is affiliated with New York University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on vaccine efficacy and the fight against HIV-1. With a focus on innovative solutions, she has established herself as a key figure in her field.
Collaborations
Some of her notable coworkers include Nathaniel R Landau and Thomas D Norton. Their collaborative efforts contribute to advancing research in immunology and vaccine development.
Conclusion
Nicole Sunseri's innovative work in the field of immunology, particularly her patent related to HIV-1, showcases her commitment to enhancing vaccine efficacy. Her contributions are vital in the ongoing battle against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
